Spectral Analysis of EEG in Familial Alzheimer's Disease with E280A Presenilin-1 Mutation Gene
Overview
Authors
Affiliations
To evaluate the hypothesis that quantitative EEG (qEEG) analysis is susceptible to detect early functional changes in familial Alzheimer's disease (AD) preclinical stages. Three groups of subjects were selected from five extended families with hereditary AD: a Probable AD group (18 subjects), an asymptomatic carrier (ACr) group (21 subjects), with the mutation but without any clinical symptoms of dementia, and a normal group of 18 healthy subjects. In order to reveal significant differences in the spectral parameter, the Mahalanobis distance (D (2)) was calculated between groups. To evaluate the diagnostic efficiency of this statistic D (2), the ROC models were used. The ROC curve was summarized by accuracy index and standard deviation. The D (2) using the parameters of the energy in the fast frequency bands shows accurate discrimination between normal and ACr groups (area ROC = 0.89) and between AD probable and ACr groups (area ROC = 0.91). This is more significant in temporal regions. Theses parameters could be affected before the onset of the disease, even when cognitive disturbance is not clinically evident. Spectral EEG parameter could be firstly used to evaluate subjects with E280A Presenilin-1 mutation without impairment in cognitive function.
van Nifterick A, de Haan W, Stam C, Hillebrand A, Scheltens P, Van Kesteren R Brain Commun. 2024; 6(6):fcae423.
PMID: 39713236 PMC: 11660908. DOI: 10.1093/braincomms/fcae423.
Fuller J, Cronin-Golomb A, Gatchel J, Norton D, Guzman-Velez E, Jacobs H J Prev Alzheimers Dis. 2019; 6(2):112-120.
PMID: 30756118 PMC: 6925534. DOI: 10.14283/jpad.2019.6.
Systematic Review on Resting-State EEG for Alzheimer's Disease Diagnosis and Progression Assessment.
Cassani R, Estarellas M, San-Martin R, Fraga F, Falk T Dis Markers. 2018; 2018:5174815.
PMID: 30405860 PMC: 6200063. DOI: 10.1155/2018/5174815.
Ochoa J, Alonso J, Duque J, Tobon C, Mananas M, Lopera F J Alzheimers Dis. 2016; 55(3):1195-1205.
PMID: 27792014 PMC: 5147495. DOI: 10.3233/JAD-160803.
Aguirre-Acevedo D, Lopera F, Henao E, Tirado V, Munoz C, Giraldo M JAMA Neurol. 2016; 73(4):431-8.
PMID: 26902171 PMC: 5505685. DOI: 10.1001/jamaneurol.2015.4851.